Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials

被引：0
|
作者：
Alexandra Curtis
Yongming Qu
机构：
[1] Lilly Corporate Center,Department of Statistics, Data and Analytics, Eli Lilly and Company
来源：
Therapeutic Innovation & Regulatory Science | 2022年 / 56卷
关键词：
Estimands; Imputation; Inference; Mixed modality; Remote;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：744 / 752
页数：8
相关论文
共 50 条
  • [31] Impact of the ICH E9 guideline statistical principles for clinical trials on the conduct of clinical trials in Japan
    Hirotsu, C
    Hothorn, LA
    DRUG INFORMATION JOURNAL, 2003, 37 (04): : 381 - 395
  • [32] Impact of the ICH E9 Guideline Statistical Principles for Clinical Trials on the Conduct of Clinical Trials in Japan
    Chihiro Hirotsu
    Ludwig A. Hothorn
    Drug information journal : DIJ / Drug Information Association, 2003, 37 : 381 - 395
  • [33] The impact of data errors on the outcome of randomized clinical trials
    Buyse, Marc
    Squifflet, Pierre
    Coart, Elisabeth
    Quinaux, Emmanuel
    Punt, Cornelis J. A.
    Saad, Everardo D.
    CLINICAL TRIALS, 2017, 14 (05) : 499 - 506
  • [34] Clinical research vehicles as a modality for medical research education and conduct of decentralized trials, supporting justice, equity, and diversity in research
    Moore, Kenneth T.
    BIOETHICS, 2025, 39 (02) : 213 - 220
  • [35] The Impact of Independent Statistical Analysis on Reported Outcomes in Cardiovascular Clinical Trials
    Esquitin, Ricardo
    Iyengar, Rupa L.
    Shah, Kshitij A.
    Razzouk, Louai
    Bashee, Sameer
    Aneja, Ashish
    Mathew, Verghese
    Farkouh, Michael E.
    CIRCULATION, 2010, 122 (21)
  • [36] Impact of monitoring approaches on data quality in clinical trials
    Andersen, Jeppe Ragnar
    von Sehested, Christoffer
    Byrjalsen, Inger
    Popik, Sara
    Follin, Anne Bo
    Bihlet, Asger Reinstrup
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (06) : 1756 - 1766
  • [37] Data-driven risk identification in phase III clinical trials using central statistical monitoring
    Catherine Timmermans
    David Venet
    Tomasz Burzykowski
    International Journal of Clinical Oncology, 2016, 21 : 38 - 45
  • [38] Data-driven risk identification in phase III clinical trials using central statistical monitoring
    Timmermans, Catherine
    Venet, David
    Burzykowski, Tomasz
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 38 - 45
  • [39] An overview of statistical methods for multiple failure time data in clinical trials
    Wei, LJ
    Glidden, DV
    STATISTICS IN MEDICINE, 1997, 16 (08) : 833 - 839
  • [40] Making correct statistical inferences in the presence of missing data using a wrong probability model
    Golden, R
    Henley, S
    White, H
    Kashner, TM
    Katz, R
    JOURNAL OF MATHEMATICAL PSYCHOLOGY, 2005, 49 (01) : 102 - 102
12345